Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kits Eyecare (TSE:KITS)
TSX:KITS
Holding TSE:KITS?
Track your performance easily
KITS Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$4.84 - C$11.75
Previous CloseC$9.13
Volume17.88K
Average Volume (3M)37.22K
Market Cap
C$288.29M
Enterprise ValueC$282.86M
Total Cash (Recent Filing)C$19.31M
Total Debt (Recent Filing)C$13.88M
Price to Earnings (P/E)―
Beta0.62
Next Earnings
Mar 05, 2025EPS Estimate
C$0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding31,551,899
10 Day Avg. Volume30,608
30 Day Avg. Volume37,224
Standard Deviation0.14
R-Squared0.00801
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)5.40
Price to Sales (P/S)2.10
Price to Cash Flow (P/CF)24.70
P/FCF Ratio29.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$15.13Price Target Upside65.36% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Kits Eyecare News
PremiumCompany Announcements
KITS Eyecare Announces Board Change and New Appointment
PremiumCompany Announcements
KITS Eyecare Achieves Record Revenue Growth
PremiumCompany Announcements
Kits Eyecare Completes Over-Allotment Shares Sale
PremiumCompany Announcements
Kits Eyecare Completes Secondary Share OfferingPremiumCompany Announcements
Kits Eyecare Completes Filing for Secondary Share OfferingPremiumCompany Announcements
Kits Eyecare Upsizes Secondary Share OfferingPremiumCompany Announcements
Kits Eyecare Launches $10.15 Million Share Offering
PremiumCompany Announcements
KITS Eyecare Achieves Record Growth in Q2 2024Bulls Say, Bears Say
Bulls Say
Financial HealthKITS finished the quarter with over $19 million of cash on hand, an improvement from the $18.4 million in Q1/24.
Market Share GrowthPreliminary Q2/24 results demonstrate sustained top-line momentum driven by continued market share gains in glasses with KITS growing at 5x the industry average.
Strategic PartnershipsKITS is collaborating with TELUS Health to become the largest provider of direct billing coverage for the optical category in Canada, reaching 70% of Canadians.
Bears Say
Profit MarginsThere are concerns about rising production costs impacting profit margins.
Regulatory ChangesRecent regulatory changes have introduced uncertainties that could affect the company's operations.
Supply ChainSupply chain disruptions have caused delays in product deliveries.
---
Options Prices
Currently, No data available
---
Ownership Overview
53.87% Insiders
1.69% Mutual Funds
― Other Institutional Investors
44.45% Public Companies and
Individual Investors
KITS FAQ
What was Kits Eyecare’s price range in the past 12 months?
Kits Eyecare lowest stock price was C$4.84 and its highest was C$11.75 in the past 12 months.
What is Kits Eyecare’s market cap?
Currently, no data Available
When is Kits Eyecare’s upcoming earnings report date?
Kits Eyecare’s upcoming earnings report date is Mar 05, 2025 which is in 111 days.
How were Kits Eyecare’s earnings last quarter?
Kits Eyecare released its earnings results on Nov 06, 2024. The company reported C$0 earnings per share for the quarter, missing the consensus estimate of C$0.008 by -C$0.008.
Is Kits Eyecare overvalued?
According to Wall Street analysts Kits Eyecare’s price is currently Undervalued.
Does Kits Eyecare pay dividends?
Kits Eyecare does not currently pay dividends.
What is Kits Eyecare’s EPS estimate?
Kits Eyecare’s EPS estimate is C$0.02.
How many shares outstanding does Kits Eyecare have?
Kits Eyecare has 31,576,529 shares outstanding.
What happened to Kits Eyecare’s price movement after its last earnings report?
Kits Eyecare reported an EPS of C$0 in its last earnings report, missing expectations of C$0.008. Following the earnings report the stock price went down -2.1%.
Which hedge fund is a major shareholder of Kits Eyecare?
Currently, no hedge funds are holding shares in TSE:KITS
---
Kits Eyecare Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
C$15.13 (65.36% Upside)
C$15.13 (65.36% Upside)
Insider Transactions
Sold Shares
Worth C$15.5M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
80.79%
12-Months-Change
Fundamentals
Return on Equity
-0.20%
Trailing 12-Months
Asset Growth
3.69%
Trailing 12-Months
Company Description
Kits Eyecare
Kits Eyecare Ltd is an online retailer of contact lenses and eyewear. Some of the brands of the company include Acuvue, Air Optix Aqua, Biofinity, Cooper Vision, and Bausch & Lomb.
---
KITS Stock 12 Month Forecast
Average Price Target
C$15.13
▲(65.36% Upside)
Technical Analysis
Best Analysts Covering KITS
1 Year
1 Year Success Rate
7/9 ratings generated profit
1 Year Average Return
+22.27%
reiterated a buy rating last month
Copying Gianluca Tucci's trades and holding each position for 1 Year would result in 77.78% of your transactions generating a profit, with an average return of +22.27% per trade.
---